Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX)

Forte Biosciences, Inc. (NASDAQ:FBRXGet Rating) saw some unusual options trading on Wednesday. Stock traders purchased 30,205 call options on the company. This represents an increase of approximately 1,663% compared to the average daily volume of 1,713 call options.

FBRX opened at $1.36 on Thursday. The stock has a fifty day moving average of $1.38 and a 200-day moving average of $1.93. Forte Biosciences has a 12-month low of $1.11 and a 12-month high of $7.26.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. lifted its holdings in shares of Forte Biosciences by 5.9% in the fourth quarter. BlackRock Inc. now owns 817,063 shares of the company’s stock valued at $1,748,000 after purchasing an additional 45,337 shares in the last quarter. State Street Corp increased its stake in shares of Forte Biosciences by 21.0% in the fourth quarter. State Street Corp now owns 561,348 shares of the company’s stock worth $1,201,000 after acquiring an additional 97,456 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Forte Biosciences by 152.0% in the fourth quarter. Geode Capital Management LLC now owns 255,471 shares of the company’s stock worth $546,000 after acquiring an additional 154,086 shares during the last quarter. Parametric Portfolio Associates LLC increased its stake in shares of Forte Biosciences by 57.2% in the fourth quarter. Parametric Portfolio Associates LLC now owns 174,724 shares of the company’s stock worth $374,000 after acquiring an additional 63,582 shares during the last quarter. Finally, Aries Wealth Management acquired a new position in shares of Forte Biosciences in the fourth quarter worth $195,000. Institutional investors own 37.11% of the company’s stock.

Forte Biosciences Company Profile (Get Rating)

Forte Biosciences, Inc operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

See Also

Receive News & Ratings for Forte Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forte Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.